MHP SE (MHPC)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 5.100 |
|---|---|
| 52-week range | 5.020 – 10.500 |
| Return, 1 month / 3 months | −28.2% / −37.7% |
| Return, 1 year / 3 years | −11.5% / +64.0% |
| Trend | Below its 200-day average |
| RSI (14) | 23 |
| Volatility (1 year) | 43.3% |
| Worst drawdown (1 year) | -50.2% |
| Average daily value traded | 0.11M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MHP SE is a Ukrainian agribusiness group based in Kyiv that produces and sells chicken meat, mainly under its consumer brand, along with sunflower oil, grain and other food products. It runs poultry farms, feed mills and processing plants, and supplies retail chains, food processors and export markets. The company also operates a distribution and retail network for its food products, serving customers in Ukraine and abroad.
MHP SE trades under the code MHPC on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MHP SE (MHPC) trades on the London Exchange in UK. It last closed at USD 5.100 on 23 October 2026.
Its price-based Market X-Ray is 23 out of 100 (a weak price profile), ranking 3,336 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.5% and over the last three months it fell 37.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 10 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -37.1% | ||
| From 52-week high | -50.2% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -37.7% | ||
| 6-month return | -42.3% | ||
| 12-month return, skipping the last month | 23.3% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -50.2% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.11M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −9.3% |
|---|---|
| 1 month | −28.2% |
| 3 months | −37.7% |
| 6 months | −42.3% |
| 1 year | −11.5% |
| 3 years | +64.0% |
| 5 years | −34.4% |
Signals
| 50-day / 200-day average | 6.753 / 8.109 |
|---|---|
| Golden / death cross (60 days) | Death, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.415 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Dec 2021 | USD 0.2603 |
| 6 May 2021 | USD 0.2403 |
| 23 Apr 2020 | USD 0.2403 |
| 28 Mar 2019 | USD 0.7074 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.